BioWorld

June 23, 2008

View Archived Issues

Rare Pulmonary Fibrosis may Have Blockbuster Potential

A handful of companies are working to develop a treatment for a rare lung disorder called pulmonary fibrosis that, by some estimates, could present a $500 million to $1.5 billion market opportunity. (BioWorld Financial Watch) Read More

Money Raised By Month

Read More

Stock Winners and Losers For The Week

Read More

Biotechnology Company Deals With Other Biotechnology Companies: May 16 - June 19, 2008

Read More

Biotechnology Company Deals With Miscellaneous Companies: May 16 - June 19, 2008

Read More

Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: May 16 - June 19, 2008

Read More

Biotech -- Biotech Collaborations: Modified Agreements: May 16 - June 19, 2008

Read More

BioWorld Stock Report For Public Biotechnology Companies

Read More